← Leaderboards
Anna C Ferrari
Mount Sinai School Of Medicine Of Cuny
$1,341,403
Attributed
$1,341,403
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $371K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$1,341,403 · 6
By mechanism
R01$1,012,941 · 1
R21$169,500 · 1
P30$118,917 · 1
M01$40,045 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchProstate NeoplasmsAndrogen ReceptorHuman SubjectMetastasisAleuritesDatabasesDesignAchievementClinical InvestigatorCore FacilityBiologyBladderCancer CenterClinical TrialsCarcinogenesis MechanismCarcinogenesisBasic ScienceCaringAppointmentBaseClinicAreaClinical Conference
Grant awards (14)
Genitourinary$31,050
P30 · FY2012 · CA · contact PI
Genitourinary$23,332
P30 · FY2011 · CA · contact PI
Genitourinary$24,559
P30 · FY2010 · CA · contact PI
Genitourinary$25,486
P30 · FY2009 · CA · contact PI
Genitourinary$14,490
P30 · FY2008 · CA · contact PI
KLF6 Gene and Clinical Correlates in Prostate Cancer$338,423
R01 · FY2005 · CA
A PHASE II TRIAL OF ARSENIC TRIOXIDE IN ADVANCED HORMONE-REFRACTORY PROSTATE$32,613
M01 · FY2005 · RR
KLF6 Gene and Clinical Correlates in Prostate Cancer$339,424
R01 · FY2004 · CA
A Phase II Trial of Arsenic Trioxide in Advanced Hormone-Refractory Prostate...$7,432
M01 · FY2004 · RR
KLF6 Gene and Clinical Correlates in Prostate Cancer$335,094
R01 · FY2003 · CA
ARSENIC TRIOXIDE IN HORMONE REFRACTORY PROSTATE CANCER$0
M01 · FY2002 · RR
ARSENIC TRIOXIDE IN HORMONE REFRACTORY PROSTATE CANCER$0
M01 · FY2001 · RR
MOLECULAR STAGING OF LYMPH NODES--OUTCOME OF PROSTATE CA$169,500
R21 · FY2000 · CA
ARSENIC TRIOXIDE IN HORMONE REFRACTORY PROSTATE CANCER$0
M01 · FY2000 · RR